Regan Zambri Long PLLC
English Español
Call Now 202-960-4596
Menu
03/17/10   |   By

FDA Forces Drugmakers to Stop Selling Unapproved Nitrogylcerin Tablets | DC Metro Area Medical Malpractice Law Blog

5 stars

Posted by: Salvatore J. Zambri, founding partner

New Jersey’s Star-Ledger reports that the FDA on Tuesday ordered “Glenmark Generics to stop selling unapproved nitroglycerin tablets for relief from chest pain.” The unapproved drugs “are different from approved nitroglycerin tablets in some ways, such as formulation and labeling, but the FDA said it has seen quality and efficacy problems with the unapproved versions.” The FDA also “advised consumers that Pfizer sells a version of the product that has been approved by regulators.” Kotec Inc. of Arizona also received a warning.

According to the Los Angeles Times’ “Booster Shots” blog, the FDA gave the two drugmakers “90 days to stop making and selling nitroglycerin tablets for use by heart patients and 180 days to stop shipping those they have made.” Reuters also covers the story.

There is great danger in selling unapproved drugs.  Drug companies must always put the safety of people over profits.  If they don’t, their greed will seriously injure and even kill Americans.

Before taking any medication, be sure to consult with your doctor, who is obligated to provide you with all risks and benefits of the drug before prescribing the medication.

About the author:

Mr. Zambri is a Past-President of the Trial Lawyers Association of Metropolitan Washington, D.C. and has been rated by Washingtonian magazine as a “Big Gun” and among the “top 1%” of all lawyers in the Washington metropolitan area.  The magazine also describes him as “one of Washington’s best–most honest and effective lawyers” who specializes in medical malpractice matters, product liability claims, and serious automobile accident claims.  Mr. Zambri has also been repeatedly named a “Super Lawyer” by Law and Politics magazine–a national publication that honors the top lawyers in America.

Mr. Zambri is regularly asked to present seminars to lawyers and doctors, as well as both medical and law students concerning medication errors, medical malpractice litigation, and safety improvements.

Mr. Zambri was sought after to publish a chapter regarding product liability litigation in Aspatore Books – a company that is touted as “the largest and most exclusive publisher of C-1 Level executives (CEO, CFO, CTO, CMO, Partner) from the world’s most respected companies and law firms.”  To read Mr. Zambri’s publication, entitled “Constantly Preparing To Win”, please click here.

If you have any questions about your legal rights, please email Mr. Zambri at szambri@reganfirm.com or call him at 202-822-1899.

If you need more information on drug related injuries, read about the decision of the U.S. Supreme Court on suing drugmakers over injuries from medicines approved by the government.

Regan Zambri Long
Posted In
Uncategorized
Share This Article

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top